Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) Key Statistics
$11.43SHZ: 002737.SZMarket Cap $6.91B
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-26.89
P/B ratioShare price divided by book value per share.
1.68
P/S ratioMarket value divided by annual revenue.
2.76
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-38.55
EV / RevenueEnterprise value against annual revenue.
1.69
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-3.72%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
46.29%
Operating marginRevenue left after operating costs.
-3.87%
Net marginRevenue left after every cost, including tax and interest.
-10.36%
Return on equityProfit as a percentage of shareholders’ equity.
-6.70%
Return on assetsProfit as a percentage of total assets.
-3.00%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
3.47
Quick ratioThe same, excluding inventory.
2.77
Debt to equityTotal borrowings against shareholders’ equity.
0.05
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-0.44
Book value per shareShareholders’ equity divided by shares outstanding.
$7.06
Shares outstandingShares currently issued.
584,000,000
Market capitalisationShare price times shares outstanding.
$6.91B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
5,025
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
1.70%
Payout ratioShare of profit paid out as dividends.
What is Sunflower Pharmaceutical Group Co., Ltd.'s P/E ratio?
Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) trades on a price-to-earnings ratio of -26.89. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Sunflower Pharmaceutical Group Co., Ltd.'s return on equity?
Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) reports a return on equity of -6.70%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Sunflower Pharmaceutical Group Co., Ltd. carry?
Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) has a debt-to-equity ratio of 0.05, which compares total borrowings with shareholders' equity.
What is Sunflower Pharmaceutical Group Co., Ltd.'s profit margin?
Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) keeps -10.36% of revenue as net profit after every cost, including tax and interest.